Avidinorubicin
Avidinorubicin is a novel anthracycline derivative that uniquely combines antitumor properties with the ability to inhibit platelet aggregation. This dual activity makes it a compound of interest for research in oncology and cardiovascular biology, applicable in both in vitro biochemical assays and in vivo model studies.
Product Specifications
CAS Number
135447-13-1
Field of Research
Infectious Disease & Virology
Smiles
O=C1C=2C3=C (C4 (C) C (OC5CC (C) (N) C (OC6CC (C) (N) C (OC7CC (OC) C (OC (CCC (O) =O) =O) C (C) O7) C (C) O6) C (C) O5) C (N (C) C) C (O) C (O3) O4) C=CC2C (=O) C=8C1=C (O) C9=C (C8O) C (OC%10CC (N (C) C) C (O) C (C) O%10) CC (C) (O) C9
Molecular Formula
C60H86N4O22
Molecular Weight
1215.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NB100-1985JF549 0.1 mL
Mouse Monoclonal CD74 Antibody (PIN.1) [Janelia Fluor 549]
Sign In for Pricing
View Details 
RPU42245-01 50 µg
Recombinant Mouse Interleukin 17 Receptor C (IL17RC)
Sign In for Pricing
View Details RPU42245-02 100 µg
Recombinant Mouse Interleukin 17 Receptor C (IL17RC)
Sign In for Pricing
View Details